Canada markets open in 1 hour 53 minutes

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.95-0.51 (-6.03%)
At close: 04:00PM EDT
9.10 +1.15 (+14.47%)
Pre-Market: 04:22AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 120.45M
Enterprise Value 93.24M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.49
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -20.30

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-76.58%
S&P500 52-Week Change 3-5.29%
52 Week High 348.96
52 Week Low 37.88
50-Day Moving Average 315.35
200-Day Moving Average 327.05

Share Statistics

Avg Vol (3 month) 372.13k
Avg Vol (10 day) 3139.76k
Shares Outstanding 513M
Implied Shares Outstanding 6N/A
Float 82.94M
% Held by Insiders 177.35%
% Held by Institutions 17.26%
Shares Short (May 12, 2022) 4308.41k
Short Ratio (May 12, 2022) 44.64
Short % of Float (May 12, 2022) 48.28%
Short % of Shares Outstanding (May 12, 2022) 42.38%
Shares Short (prior month Apr 13, 2022) 4273.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.91%
Return on Equity (ttm)-24.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-5.94M
Diluted EPS (ttm)-0.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.74M
Total Cash Per Share (mrq)1.52
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)81.86
Book Value Per Share (mrq)1.51

Cash Flow Statement

Operating Cash Flow (ttm)-5.71M
Levered Free Cash Flow (ttm)-3.51M